ClinicalTrials.Veeva

Menu

Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma

S

Sohag University

Status

Not yet enrolling

Conditions

Non-melanoma Skin Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05550766
Soh-Med-22-09-05

Details and patient eligibility

About

Vitamin D has a crucial role in cancer control and prevention.vitamin D receptor (VDR) and its heterodimer Retinoid X receptor (RXR) are equally important in the cell. This ligand (vitamin D) and receptors (VDR-RXR) complex together triggers downstream DNA damage response in the cell.

Retinoid receptors are a superfamily of nuclear receptors. The preferred receptor that attaches to VDR is RXR, with its subunits α, β and γ. RXR α is more frequent in the skin than other tissues, while β occurs in internal organs and γ is frequently related to neural disorders.

the investigator hopes to assess prognosis of SCC & BCC by using RXR-α biomarker & attempts to use it in the treatment.

Enrollment

50 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Squamous cell carcinoma and basal cell carcinoma.
  2. Incisional & excisional biopsies.
  3. All the studied cases include sufficient materials for the immunohistochemical study 4. Complete clinical data

Exclusion criteria

  1. Patients with a history of preoperative chemotherapy and/or radiotherapy.
  2. Insufficient or tiny tissue biopsies.

Trial contacts and locations

0

Loading...

Central trial contact

Fatma M.Hamdan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems